0001741773-24-000993.txt : 20240229 0001741773-24-000993.hdr.sgml : 20240229 20240229144014 ACCESSION NUMBER: 0001741773-24-000993 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 PERIOD START: 20240930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JANUS INVESTMENT FUND CENTRAL INDEX KEY: 0000277751 ORGANIZATION NAME: IRS NUMBER: 840592523 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-01879 FILM NUMBER: 24702856 BUSINESS ADDRESS: STREET 1: 151 DETROIT STREET CITY: DENVER STATE: CO ZIP: 80206 BUSINESS PHONE: 303-333-3863 MAIL ADDRESS: STREET 1: 151 DETROIT STREET CITY: DENVER STATE: CO ZIP: 80206 FORMER COMPANY: FORMER CONFORMED NAME: JANUS FUND /MD/ DATE OF NAME CHANGE: 19870701 0000277751 S000010490 Janus Henderson Enterprise Fund C000028952 Class T JAENX C000077737 Class A JDMAX C000077738 Class C JGRCX C000077739 Class I JMGRX C000077740 Class R JDMRX C000077741 Class S JGRTX C000083535 Class D JANEX C000114883 Class N JDMNX NPORT-P 1 primary_doc.xml NPORT-Pfalse0000277751XXXXXXXXS000010490C000028952C000077737C000077738C000077739C000077740C000077741C000083535C000114883JANUS INVESTMENT FUND811-018790000277751W6UYDZFUOFJ4HQQ32382151 DETROIT STREETDENVER802063033333863Janus Henderson Enterprise FundS000010490TJ2Y3QQ1QRI8KQ84FR292024-09-302023-12-31N1971738872361996702196553920210000000000000661820NRussell Midcap Growth TR IndexRUSSELL.MC.D94641N/AN/ARoyal Bank of CanadaN/A44400PAUSD444000LongSTIVCORPUSN22024-01-02Fixed5.31NNNNNAlliant Energy Corp5493009ML300G373MZ12Alliant Energy Corp0188021086444272NSUSD3305911541.682LongECCORPUSN1NNNAmeren CorpXRZQ5S7HYJFPHJ78L959Ameren Corp0236081023882613NSUSD2808682241.429LongECCORPUSN1NNNAramark549300MR6PG2DWZUIL39Aramark03852U1067996214NSUSD2246936131.143LongECCORPUSN1NNNAtlassian Corp549300V7ZY5P02D2MY38Atlassian Corp - Class A049468101396439NSUSD942969810.48LongECCORPUSN1NNNAvantor IncN/AAvantor Inc05352A1009942880NSUSD2269959501.155LongECCORPUSN1NNNW R Berkley CorpSQOAGCLKBDWNVYV1OV80WR Berkley Corp0844231026097313NSUSD4312019752.194LongECCORPUSN1NNNBioMarin Pharmaceutical IncNSLL8ITTRR0J5HEMR848BioMarin Pharmaceutical Inc09061G1011318485NSUSD1271283240.647LongECCORPUSN1NNNBoston Scientific CorpY6ZDD9FP4P8JSSJMW954Boston Scientific Corp10113710710063108NSUSD5817482732.96LongECCORPUSN1NNNBroadridge Financial Solutions549300KZDJZQ2YIHRC28Broadridge Financial Solutions Inc11133T1031784760NSUSD3672143701.868LongECCORPUSN1NNNBurlington Stores Inc5299003Z37DVGKKC1W09Burlington Stores Inc122017106704259NSUSD1369642900.697LongECCORPUSN1NNNCboe Global Markets Inc529900RLNSGA90UPEH54Cboe Global Markets Inc12503M108786593NSUSD1404540460.715LongECCORPUSN1NNNCarMax Inc529900F60CID3NCZM330CarMax Inc1431301023484996NSUSD2674385931.361LongECCORPUSN1NNNCatalent IncN/ACatalent Inc1488061023341180NSUSD1501192170.764LongECCORPUSN1NNNCeridian HCM Holding Inc549300T64GVCHFJ8L449Ceridian HCM Holding Inc15677J1083369070NSUSD2261319781.15LongECCORPUSN1NNNClean Harbors Inc5493000SJVZVZJKHJF48Clean Harbors Inc184496107863429NSUSD1506769950.767LongECCORPUSN1NNNCooper Cos Inc/TheQJKMVPIGLH7530PCUE20Cooper Cos Inc216648402493131NSUSD1866204960.949LongECCORPUSN1NNNCorteva Inc549300WZN9I2QKLS0O94Corteva Inc22052L1044010608NSUSD1921883350.978LongECCORPUSN1NNNDENTSPLY SIRONA Inc9NHEHR1SOZCYXDO8HO28DENTSPLY SIRONA Inc24906P1094793558NSUSD1706027290.868LongECCORPUSN1NNNDollar Tree Inc549300PMSTQITB1WHR43Dollar Tree Inc2567461081029817NSUSD1462855050.744LongECCORPUSN1NNNDynatrace IncN/ADynatrace Inc2681501092282672NSUSD1248393320.635LongECCORPUSN1NNNVestis CorpN/AVESTIS CORP29430C102477746NSUSD100995500.051LongECCORPUSN1NNNFidelity National Information6WQI0GK1PRFVBA061U48Fidelity National Information Services Inc31620M1062246616NSUSD1349542230.687LongECCORPUSN1NNNFortive Corp549300MU9YQJYHDQEF63Fortive Corp34959J1083257483NSUSD2398484731.22LongECCORPUSN1NNNFrontdoor Inc5493008RB0JZJI3QGZ06frontdoor Inc35905A1091351276NSUSD475919410.242LongECCORPUSN1NNNGildan Activewear Inc549300SB3IBI34M00Z45Gildan Activewear Inc3759161034810874NSUSD1590474940.809LongECCORPCAN1NNNGlobal Payments Inc549300NOMHGVQBX6S778Global Payments Inc37940X1021220699NSUSD1550287730.789LongECCORPUSN1NNNGoDaddy Inc549300J8H1TB0I2CB447GoDaddy Inc3802371075720152NSUSD6072513363.089LongECCORPUSN1NNNJB Hunt Transport Services Inc549300XCD1MPI1C5GK90JB Hunt Transport Services Inc4456581072127631NSUSD4249730162.162LongECCORPUSN1NNNICU Medical Inc5493003NRW7LS2QZRH60ICU Medical Inc44930G1071230753NSUSD1227553040.625LongECCORPUSN1NNNIllumina IncSQ95QG8SR5Q56LSNF682ILLUMINA INC452327109899120NSUSD1251934690.637LongECCORPUSN1NNNIngersoll Rand Inc5299004C02FMZCUOIR50Ingersoll Rand Inc45687V1064415214NSUSD3414726511.737LongECCORPUSN1NNNZiff Davis Inc5493008OJYGLHD7MXA18Ziff Davis Inc48123V1021202966NSUSD808272860.411LongECCORPUSN1NNNKLA Corp549300H0BF5JCG96TJ81KLA Corp482480100339833NSUSD1975449231.005LongECCORPUSN1NNNLPL Financial Holdings Inc549300XROQ4Y8G2L7682LPL Financial Holdings Inc50212V1001310232NSUSD2982350081.517LongECCORPUSN1NNNL3Harris Technologies Inc549300UTE50ZMDBG8A20L3Harris Technologies Inc5024311091370643NSUSD2886848291.469LongECCORPUSN1NNNLam Research Corp549300I4GMO6D34U1T02LAM RESEARCH CORP512807108231878NSUSD1816207620.924LongECCORPUSN1NNNLamar Advertising Co529900Y8WW4MKVPTB543Lamar Advertising Co5128161092544178NSUSD2703952381.376LongECCORPUSN1NNNLiberty Media Corp-Liberty For549300ZKUTPIBZLWLL89Liberty Media Corp-Liberty Formula One - Series C5312297555403914NSUSD3411490911.736LongECCORPUSN1NNNLiberty Media Corp-Liberty For549300ZKUTPIBZLWLL89Liberty Media Corp-Liberty Formula One - Series A531229771503190NSUSD291749560.148LongECCORPUSN1NNNMicrochip Technology Inc5493007PTFULNYZJ1R12MICROCHIP TECHNOLOGY INC5950171043857683NSUSD3478858531.77LongECCORPUSN1NNNON Semiconductor CorpZV20P4CNJVT8V1ZGJ064ON Semiconductor Corp6821891056027578NSUSD5034835902.562LongECCORPUSN1NNNONEOK Inc2T3D6M0JSY48PSZI1Q41ONEOK Inc6826801034027560NSUSD2828152631.439LongECCORPUSN1NNNRevvity Inc549300IKL1SDPFI7N655PERKINELMER INC7140461093773624NSUSD4124948392.099LongECCORPUSN1NNNRB Global Inc5493002H8U24DJXQ4886RB Global Inc74935Q1072403064NSUSD1607409510.818LongECCORPCAN1NNNRegal Rexnord CorpQH78R09VCJGQKPBPYU33Regal Beloit Corp758750103563624NSUSD834276240.424LongECCORPUSN1NNNRyan Specialty Holdings IncN/ARyan Specialty Group Holdings Inc CL A78351F1072376755NSUSD1022480000.52LongECCORPUSN1NNNSS&C Technologies Holdings Inc529900POY8H7NPPNKK71SS&C Technologies Holdings Inc78467J1008601810NSUSD5256566092.674LongECCORPUSN1NNNSarepta Therapeutics Inc549300IKDPIED8J8IG21Sarepta Therapeutics Inc8036071001033849NSUSD996940590.507LongECCORPUSN1NNNCharles Schwab Corp/The549300VSGCJ7E698NM85Charles Schwab Corp8085131052572242NSUSD1769702500.9LongECCORPUSN1NNNTFI International Inc5493007R9W7KO7SJN678TFI International Inc87241L1091889400NSUSD2569206121.307LongECCORPCAN1NNTeledyne Technologies Inc549300VSMO9KYQWDND94Teledyne Technologies Inc879360105909004NSUSD4056793952.064LongECCORPUSN1NNNTeleflex IncUUL85LWXB4NGSWWXIQ25Teleflex Inc8793691062140377NSUSD5336816012.715LongECCORPUSN1NNNTransUnion549300ZS772LUNUMRB03TransUnion89400J1072085935NSUSD1433245940.729LongECCORPUSN1NNNJanus Henderson US Holdings Inc8T2ZO87FU1KVPZIG9I59Janus Henderson Cash Liquidity FundN/A771652626NSUSD7718069563.927LongECPFUSN2NNNJanus Henderson Cash Collateral FundN/AJanus Henderson Cash Collateral FundN/A177600NSUSD1776000.001LongECPFUSN2NNVeralto Corp635400FJE6GSOJUSNY27Veralto Corp92338C1032191536NSUSD1802757510.917LongECCORPUSN1NNNWestinghouse Air Brake Technol06BTX5UWZD0GQ5N5Y745WABTEC CORP9297401082676153NSUSD3396038161.728LongECCORPUSN1NNNWaters Corp5T547R1474YC9HOD8Q74Waters Corp941848103532160NSUSD1752030370.891LongECCORPUSN1NNNWayfair Inc54930027N9ZAVYFDHK53Wayfair Inc - Class A94419L101189780NSUSD117094260.06LongECCORPUSN1NNNWEX IncT9M5IGROL1TL1G5OV478WEX Inc96208T1042465621NSUSD4796865662.44LongECCORPUSN1NNNIntact Financial Corp5493009LXGE7Y4U9OY43INTACT FINANCIAL CORP45823T1063417236NS5258040092.675LongECCORPCAN1NNNRentokil Initial PLC549300VN4WV7Z6T14K68Rentokil Initial PLCG7494G1058760830NS492146340.25LongECCORPGBN1NNNConstellation Software Inc/Can549300B6PYHMCTDWQV29Constellation Software Inc/Canada21037X100319588NS7924619744.032LongECCORPCAN1NNNEntain PLC213800GNI3K45LQR8L28Entain PLCG427A610311220699NS1421677490.723LongECCORPGBN1NNNTopicus.com IncN/ATopicus.com Inc89072T102849991NS572520170.291LongECCORPCAN1NNNAmdocs Ltd549300HQV672RJ7RQV66Amdocs LtdG026021034999330NSUSD4393911142.235LongECCORPUSN1NNNCimpress PLC549300X1IFD75XISOR81Cimpress PLCG2143T1032136289NSUSD1710099340.87LongECCORPUSN1NNNFerguson PLC213800DU1LGY3R2S2X42Ferguson PLCG3421J1062034951NSUSD3928879901.999LongECCORPUSN1NNNSensata Technologies Holding P529900MS7KFYCY9MS037Sensata Technologies Holding PLCG8060N1026977054NSUSD2621279191.334LongECCORPUSN1NNNSTERIS PLCN/ASTERIS PLCG8473T100828828NSUSD1822178360.927LongECCORPUSN1NNNTE Connectivity Ltd894500ZRIX9K13RHXR17TE CONNECTIVITY LTDH849891041392552NSUSD1956535560.995LongECCORPUSN1NNNNXP Semiconductors NV724500M9BY5293JDF951NXP Semiconductors NVN6596X1091800147NSUSD4134577632.104LongECCORPUSN1NNNFlex Ltd549300EAQH74YHD07T53Flex LtdY2573F10217175336NSUSD5231607352.662LongECCORPUSN1NNNArgenx SE7245009C5FZE6G9ODQ71Argenx SE (ADR)04016X101348377NSUSD1325330620.674LongCORPUSN1NNNAscendis Pharma A/S549300B66JN3W3J8GH73Ascendis Pharma A/S (ADR)04351P1011043428NSUSD1314197570.669LongCORPUSN1NNNNice Ltd254900YTY4EF5Z4W0A51Nice Ltd (ADR)6536561081210744NSUSD2415555351.229LongCORPUSN1NNNRentokil Initial PLC549300VN4WV7Z6T14K68Rentokil Initial PLC (ADR)7601251046389737NSUSD1828103760.93LongCORPUSN1NNNRyanair Holdings PLC635400BR2ROC1FVEBQ56Ryanair Holdings PLC (ADR)7835132031864314NSUSD2486249151.265LongCORPUSN1NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-1821016-0.009N/ADFEUSN2Citibank, National AssociationE57ODZWZ7FF32TWEFA7678190000CAD57210645USD2024-01-18-1821016NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-3317379-0.017N/ADFEUSN2Citibank, National AssociationE57ODZWZ7FF32TWEFA7670845000EUR74939246USD2024-01-18-3317379NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-2614975-0.013N/ADFEUSN2HSBC Securities (USA), Inc.CYYGQCGNHMHPSMRL3R97111506000CAD81569503USD2024-01-18-2614975NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-1921455-0.01N/ADFEUSN2HSBC Securities (USA), Inc.CYYGQCGNHMHPSMRL3R9741043000EUR43415359USD2024-01-18-1921455NNNN/AN/ASell USD / Buy CADN/A1NCUSD314370N/ADFEUSN2Morgan Stanley & Co. International PLC4PQUHN3JPFGFNF3BB653977213USD1336000CAD2024-01-1831437NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-218300-0.001N/ADFEUSN2Morgan Stanley & Co. International PLC4PQUHN3JPFGFNF3BB6534659000EUR4928113USD2024-01-18-218300NNNN/AN/ASell USD / Buy CADN/A1NCUSD3212540.002N/ADFEUSN2Bank of America, National AssociationB4TYDEB6GKMZO031MB279961535USD13620000CAD2024-01-18321254NNNN/AN/ASell USD / Buy EURN/A1NCUSD4830640.002N/ADFEUSN2Bank of America, National AssociationB4TYDEB6GKMZO031MB2710834847USD10246000EUR2024-01-18483064NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-3296839-0.017N/ADFEUSN2Barclays Capital, Inc.AC28XWWI3WIBK2824319137142000CAD100242233USD2024-01-18-3296839NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-2876603-0.015N/ADFEUSN2Barclays Capital, Inc.AC28XWWI3WIBK282431960568000EUR64027868USD2024-01-18-2876603NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-3879071-0.02N/ADFEUSN2JPMorgan Chase Bank, National Association7H6GLXDRUGQFU57RNE97159723000CAD116708138USD2024-01-18-3879071NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-4037943-0.021N/ADFEUSN2JPMorgan Chase Bank, National Association7H6GLXDRUGQFU57RNE9785397000EUR90293075USD2024-01-18-4037943NNNN/AN/ASell USD / Buy EURN/A1NCUSD2274600.001N/ADFEUSN2BNP ParibasR0MUWSFPU8MPRO8K5P835074704USD4800000EUR2024-01-18227460NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-204071-0.001N/ADFEUSN2Goldman Sachs & Co. LLCFOR8UP27PHTHYVLBNG308409000CAD6144531USD2024-01-18-204071NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-663810N/ADFEUSN2Goldman Sachs & Co. LLCFOR8UP27PHTHYVLBNG301402000EUR1482293USD2024-01-18-66381NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-3951247-0.02N/ADFEUSN2State Street Bank and Trust Company571474TGEMMWANRLN572163996000CAD119861980USD2024-01-18-3951247NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-5650362-0.029N/ADFEUSN2State Street Bank and Trust Company571474TGEMMWANRLN572120976000EUR127981841USD2024-01-18-5650362NNNN/AN/ASell USD / Buy EURN/A1NCUSD3453020.002N/ADFEUSN2JPMorgan Chase Bank, National Association7H6GLXDRUGQFU57RNE978637448USD8132000EUR2024-01-18345302NNNN/AN/ASell USD / Buy CADN/A1NCUSD4870960.002N/ADFEUSN2State Street Bank and Trust Company571474TGEMMWANRLN57212373939USD17035000CAD2024-01-18487096NNNN/AN/ASell USD / Buy EURN/A1NCUSD3490940.002N/ADFEUSN2Barclays Capital, Inc.AC28XWWI3WIBK28243199245613USD8686000EUR2024-01-18349094NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-595826-0.003N/ADFEUSN2Goldman Sachs & Co. LLCFOR8UP27PHTHYVLBNG3012738000EUR13474791USD2024-01-18-595826NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-547202-0.003N/ADFEUSN2JPMorgan Chase Bank, National Association7H6GLXDRUGQFU57RNE9718697000CAD13568605USD2024-01-18-547202NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-218837-0.001N/ADFEUSN2HSBC Securities (USA), Inc.CYYGQCGNHMHPSMRL3R978049000EUR8672229USD2024-01-18-218837NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-461354-0.002N/ADFEUSN2Goldman Sachs & Co. LLCFOR8UP27PHTHYVLBNG3014701000EUR15777628USD2024-01-18-461354NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-540999-0.003N/ADFEUSN2Citibank, National AssociationE57ODZWZ7FF32TWEFA7619202000CAD13956072USD2024-01-18-540999NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-336270-0.002N/ADFEUSN2Goldman Sachs & Co. LLCFOR8UP27PHTHYVLBNG309780000EUR10466889USD2024-01-18-336270NNNN/AN/ASell CAD / Buy USDN/A1NCUSD-412929-0.002N/ADFEUSN2Bank of America, National AssociationB4TYDEB6GKMZO031MB2716819000CAD12285031USD2024-01-18-412929NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-113229-0.001N/ADFEUSN2JPMorgan Chase Bank, National Association7H6GLXDRUGQFU57RNE9713841000EUR15175782USD2024-01-18-113229NNNN/AN/ASell USD / Buy EURN/A1NCUSD331290N/ADFEUSN2State Street Bank and Trust Company571474TGEMMWANRLN57214039698USD12740000EUR2024-01-1833129NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-197380-0.001N/ADFEUSN2Goldman Sachs & Co. LLCFOR8UP27PHTHYVLBNG3010623000EUR11536971USD2024-01-18-197380NNNN/AN/ASell EUR / Buy USDN/A1NCUSD-410729-0.002N/ADFEUSN2HSBC Securities (USA), Inc.CYYGQCGNHMHPSMRL3R9715068000EUR16233647USD2024-01-18-410729NNNN/AN/ASell USD / Buy CADN/A1NCUSD1179900.001N/ADFEUSN2Citibank, National AssociationE57ODZWZ7FF32TWEFA7615580249USD20793000CAD2024-01-18117990NNNN/AN/ASell USD / Buy EURN/A1NCUSD1549330.001N/ADFEUSN2Citibank, National AssociationE57ODZWZ7FF32TWEFA7636453194USD33141000EUR2024-01-18154933NNNN/AN/ASell USD / Buy CADN/A1NCUSD-102190N/ADFEUSN2State Street Bank and Trust Company571474TGEMMWANRLN57211249563USD14887000CAD2024-01-18-10219NNNN/AN/ASell EUR / Buy USDN/A1NCUSD1076200.001N/ADFEUSN2JPMorgan Chase Bank, National Association7H6GLXDRUGQFU57RNE9715933000EUR17707490USD2024-01-18107620NNNN/AN/AConstellation Software Inc/CanadaN/A319588NS240N/ADECORPUSN3N/AN/ACallPurchasedConstellation Software IncConstellation Software Inc31958811.5CAD2040-03-31XXXX24NNNN/AN/ARYANAIR HOLDINGS PLCN/A25958221OUNotional3036050.002N/ADEUSN2UBS AG254900R882POXXVAK772RYANAIR HOLDINGS PLCRYANAIR HOLDINGS PLCYRYANAIR HOLDINGS PLC2025-01-080USD0USD25958221EUR303605NNN2024-02-14JANUS INVESTMENT FUNDJESPER NERGAARDJESPER NERGAARDVP, CFO, TREASURER, AND PRINCIPAL ACCOUNTING OFFICERXXXX NPORT-EX 2 nportex-09.htm

Janus Henderson Enterprise Fund

Schedule of Investments (unaudited)

December 31, 2023

        

Shares or
Principal Amounts

  

Value

 

Common Stocks– 96.3%

   

Aerospace & Defense – 1.5%

   
 

L3Harris Technologies Inc

 

1,370,643

  

$288,684,829

 

Airlines – 1.3%

   
 

Ryanair Holdings PLC (ADR)*

 

1,864,314

  

248,624,915

 

Biotechnology – 2.5%

   
 

Argenx SE (ADR)*

 

348,377

  

132,533,062

 
 

Ascendis Pharma A/S (ADR)*

 

1,043,428

  

131,419,757

 
 

BioMarin Pharmaceutical Inc*

 

1,318,485

  

127,128,324

 
 

Sarepta Therapeutics Inc*

 

1,033,849

  

99,694,059

 
  

490,775,202

 

Capital Markets – 3.1%

   
 

Cboe Global Markets Inc

 

786,593

  

140,454,046

 
 

Charles Schwab Corp

 

2,572,242

  

176,970,250

 
 

LPL Financial Holdings Inc

 

1,310,232

  

298,235,008

 
  

615,659,304

 

Chemicals – 1.0%

   
 

Corteva Inc

 

4,010,608

  

192,188,335

 

Commercial Services & Supplies – 4.6%

   
 

Cimpress PLC*

 

2,136,289

  

171,009,934

 
 

Clean Harbors Inc*

 

863,429

  

150,676,995

 
 

RB Global Inc

 

2,403,064

  

160,740,951

 
 

Rentokil Initial PLC

 

8,760,830

  

49,214,634

 
 

Rentokil Initial PLC (ADR)

 

6,389,737

  

182,810,376

 
 

Veralto Corp

 

2,191,536

  

180,275,751

 
 

Vestis Corp

 

477,746

  

10,099,550

 
  

904,828,191

 

Diversified Consumer Services – 0.2%

   
 

Frontdoor Inc*

 

1,351,276

  

47,591,941

 

Diversified Financial Services – 3.9%

   
 

Fidelity National Information Services Inc

 

2,246,616

  

134,954,223

 
 

Global Payments Inc

 

1,220,699

  

155,028,773

 
 

WEX Inc*

 

2,465,621

  

479,686,566

 
  

769,669,562

 

Electric Utilities – 1.7%

   
 

Alliant Energy Corp

 

6,444,272

  

330,591,154

 

Electrical Equipment – 1.8%

   
 

Regal Beloit Corp

 

563,624

  

83,427,624

 
 

Sensata Technologies Holding PLC

 

6,977,054

  

262,127,919

 
  

345,555,543

 

Electronic Equipment, Instruments & Components – 5.7%

   
 

Flex Ltd*

 

17,175,336

  

523,160,735

 
 

TE Connectivity Ltd

 

1,392,552

  

195,653,556

 
 

Teledyne Technologies Inc*

 

909,004

  

405,679,395

 
  

1,124,493,686

 

Entertainment – 1.9%

   
 

Liberty Media Corp-Liberty Formula One - Series A*

 

503,190

  

29,174,956

 
 

Liberty Media Corp-Liberty Formula One - Series C*

 

5,403,914

  

341,149,091

 
  

370,324,047

 

Food & Staples Retailing – 0.7%

   
 

Dollar Tree Inc*

 

1,029,817

  

146,285,505

 

Health Care Equipment & Supplies – 9.0%

   
 

Boston Scientific Corp*

 

10,063,108

  

581,748,273

 
 

Cooper Cos Inc

 

493,131

  

186,620,496

 
 

Dentsply Sirona Inc

 

4,793,558

  

170,602,729

 
 

ICU Medical Inc*

 

1,230,753

  

122,755,304

 
 

STERIS PLC

 

828,828

  

182,217,836

 
 

Teleflex Inc

 

2,140,377

  

533,681,601

 
  

1,777,626,239

 

Hotels, Restaurants & Leisure – 1.9%

   
 

Aramark

 

7,996,214

  

224,693,613

 
 

Entain PLC

 

11,220,699

  

142,167,749

 
  

366,861,362

 

Information Technology Services – 5.3%

   
 

Amdocs Ltd

 

4,999,330

  

439,391,114

 
 

GoDaddy Inc*

 

5,720,152

  

607,251,336

 
  

1,046,642,450

 

Insurance – 5.4%

   
 

Intact Financial Corp

 

3,417,236

  

525,804,009

 
 

Ryan Specialty Group Holdings Inc - Class A*

 

2,376,755

  

102,248,000

 


        

Shares or
Principal Amounts

  

Value

 

Common Stocks– (continued)

   

Insurance– (continued)

   
 

WR Berkley Corp

 

6,097,313

  

$431,201,975

 
  

1,059,253,984

 

Interactive Media & Services – 0.4%

   
 

Ziff Davis Inc*

 

1,202,966

  

80,827,286

 

Life Sciences Tools & Services – 4.8%

   
 

Avantor Inc*

 

9,942,880

  

226,995,950

 
 

Illumina Inc*

 

899,120

  

125,193,469

 
 

PerkinElmer Inc

 

3,773,624

  

412,494,839

 
 

Waters Corp*

 

532,160

  

175,203,037

 
  

939,887,295

 

Machinery – 4.7%

   
 

Fortive Corp

 

3,257,483

  

239,848,473

 
 

Ingersoll Rand Inc

 

4,415,214

  

341,472,651

 
 

Wabtec Corp

 

2,676,153

  

339,603,816

 
  

920,924,940

 

Multi-Utilities – 1.4%

   
 

Ameren Corp

 

3,882,613

  

280,868,224

 

Oil, Gas & Consumable Fuels – 1.4%

   
 

ONEOK Inc

 

4,027,560

  

282,815,263

 

Pharmaceuticals – 0.8%

   
 

Catalent Inc*

 

3,341,180

  

150,119,217

 

Professional Services – 6.4%

   
 

Broadridge Financial Solutions Inc

 

1,784,760

  

367,214,370

 
 

Ceridian HCM Holding Inc*

 

3,369,070

  

226,131,978

 
 

SS&C Technologies Holdings Inc

 

8,601,810

  

525,656,609

 
 

TransUnion

 

2,085,935

  

143,324,594

 
  

1,262,327,551

 

Road & Rail – 3.5%

   
 

JB Hunt Transport Services Inc

 

2,127,631

  

424,973,016

 
 

TFI International Inc#

 

1,889,400

  

256,920,612

 
  

681,893,628

 

Semiconductor & Semiconductor Equipment – 8.4%

   
 

KLA Corp

 

339,833

  

197,544,923

 
 

Lam Research Corp

 

231,878

  

181,620,762

 
 

Microchip Technology Inc

 

3,857,683

  

347,885,853

 
 

NXP Semiconductors NV

 

1,800,147

  

413,457,763

 
 

ON Semiconductor Corp*

 

6,027,578

  

503,483,590

 
  

1,643,992,891

 

Software – 6.7%

   
 

Atlassian Corp - Class A*

 

396,439

  

94,296,981

 
 

Constellation Software Inc/Canada

 

319,588

  

792,461,974

 
 

Dynatrace Inc*

 

2,282,672

  

124,839,332

 
 

Nice Ltd (ADR)*

 

1,210,744

  

241,555,535

 
 

Topicus.com Inc*

 

849,991

  

57,252,017

 
  

1,310,405,839

 

Specialized Real Estate Investment Trusts (REITs) – 1.4%

   
 

Lamar Advertising Co

 

2,544,178

  

270,395,238

 

Specialty Retail – 2.1%

   
 

Burlington Stores Inc*

 

704,259

  

136,964,290

 
 

CarMax Inc*

 

3,484,996

  

267,438,593

 
 

Wayfair Inc - Class A*

 

189,780

  

11,709,426

 
  

416,112,309

 

Textiles, Apparel & Luxury Goods – 0.8%

   
 

Gildan Activewear Inc

 

4,810,874

  

159,047,494

 

Trading Companies & Distributors – 2.0%

   
 

Ferguson PLC

 

2,034,951

  

392,887,990

 

Total Common Stocks (cost $12,038,216,577)

 

18,918,161,414

 

Warrants– 0%

   

Software – 0%

   
 

Constellation Software Inc/Canada, expires 3/31/40*((cost $0)

 

319,588

  

24

 

Investment Companies– 3.9%

   

Money Markets – 3.9%

   
 

Janus Henderson Cash Liquidity Fund LLC, 5.3879%ºº,£((cost $771,780,350)

 

771,652,626

  

771,806,956

 

2


        

Shares or
Principal Amounts

  

Value

 

Investments Purchased with Cash Collateral from Securities Lending– 0%

   

Investment Companies – 0%

   
 

Janus Henderson Cash Collateral Fund LLC, 5.2936%ºº,£

 

177,600

  

$177,600

 

Time Deposits – 0%

   
 

Royal Bank of Canada, 5.3100%, 1/2/24

 

$44,400

  

44,400

 

Total Investments Purchased with Cash Collateral from Securities Lending (cost $222,000)

 

222,000

 

Total Investments (total cost $12,810,218,927) – 100.2%

 

19,690,190,394

 

Liabilities, net of Cash, Receivables and Other Assets – (0.2)%

 

(34,783,169)

 

Net Assets – 100%

 

$19,655,407,225

 
      

Summary of Investments by Country - (Long Positions) (unaudited)

 
    

% of

 
    

Investment

 

Country

 

Value

 

Securities

 

United States

 

$16,609,637,285

 

84.3

%

Canada

 

1,952,227,081

 

9.9

 

United Kingdom

 

374,192,759

 

1.9

 

Ireland

 

248,624,915

 

1.3

 

Israel

 

241,555,535

 

1.2

 

Belgium

 

132,533,062

 

0.7

 

Denmark

 

131,419,757

 

0.7

 
      
      

Total

 

$19,690,190,394

 

100.0

%

 

3


Schedules of Affiliated Investments – (% of Net Assets)

           
 

Dividend

Income(1)

Realized

Gain/(Loss)(1)

Change in

Unrealized

Appreciation/

Depreciation(1)

Value

at 12/31/23

Common Stocks - 3.9%

Commercial Services & Supplies - 0.9%

 
 

Cimpress PLC*

$

-

$

-

$

21,448,341

$

171,009,934

Diversified Financial Services - 2.4%

 
 

WEX Inc*

 

-

 

-

 

15,927,912

 

479,686,566

Health Care Equipment & Supplies - 0.6%

 
 

ICU Medical Inc*

 

-

 

-

 

(23,716,611)

 

122,755,304

Total Common Stocks

$

-

$

-

$

13,659,642

$

773,451,804

Investment Companies - 3.9%

Money Markets - 3.9%

 
 

Janus Henderson Cash Liquidity Fund LLC, 5.3879%ºº

 

12,021,010

 

-

 

(94,278)

 

771,806,956

Investments Purchased with Cash Collateral from Securities Lending - 0.0%

Investment Companies - 0.0%

 
 

Janus Henderson Cash Collateral Fund LLC, 5.2936%ºº

 

43,091

 

-

 

-

 

177,600

Total Affiliated Investments - 7.8%

$

12,064,101

$

-

$

13,565,364

$

1,545,436,360

(1) For securities that were affiliated for a portion of the period ended December 31, 2023, this column reflects amounts for the entire period ended December 31, 2023 and not just the period in which the security was affiliated.

           
 

Value

at 9/30/23

Purchases

Sales Proceeds

Value

at 12/31/23

Common Stocks - 3.9%

Commercial Services & Supplies - 0.9%

 
 

Cimpress PLC*

 

149,561,593

 

-

 

-

 

171,009,934

Diversified Financial Services - 2.4%

 
 

WEX Inc*

 

463,758,654

 

-

 

-

 

479,686,566

Health Care Equipment & Supplies - 0.6%

 
 

ICU Medical Inc*

 

146,471,915

 

-

 

-

 

122,755,304

Investment Companies - 3.9%

Money Markets - 3.9%

 
 

Janus Henderson Cash Liquidity Fund LLC, 5.3879%ºº

 

943,056,565

 

430,237,397

 

(601,392,728)

 

771,806,956

Investments Purchased with Cash Collateral from Securities Lending - 0.0%

Investment Companies - 0.0%

 
 

Janus Henderson Cash Collateral Fund LLC, 5.2936%ºº

 

8,793,960

 

348,130,646

 

(356,747,006)

 

177,600

4


       

Schedule of Forward Foreign Currency Exchange Contracts

      
         

Counterparty/

Foreign Currency

Settlement

Date

Foreign Currency

Amount (Sold)/

Purchased

 

USD Currency

Amount (Sold)/

Purchased

 

Market Value and

Unrealized

Appreciation/

(Depreciation)

 

Bank of America, National Association:

        

Canadian Dollar

1/18/24

13,620,000

$

(9,961,535)

$

321,254

 

Canadian Dollar

1/18/24

(16,819,000)

 

12,285,031

 

(412,929)

 

Euro

1/18/24

10,246,000

 

(10,834,847)

 

483,064

 
         
      

391,389

  

Barclays Capital, Inc.:

        

Canadian Dollar

1/18/24

(137,142,000)

 

100,242,233

 

(3,296,839)

 

Euro

1/18/24

8,686,000

 

(9,245,613)

 

349,094

 

Euro

1/18/24

(60,568,000)

 

64,027,868

 

(2,876,603)

 
         
      

(5,824,348)

  

BNP Paribas:

        

Euro

1/18/24

4,800,000

 

(5,074,704)

 

227,460

 

Citibank, National Association:

        

Canadian Dollar

1/18/24

20,793,000

 

(15,580,249)

 

117,990

 

Canadian Dollar

1/18/24

(97,392,000)

 

71,166,717

 

(2,362,015)

 

Euro

1/18/24

33,141,000

 

(36,453,194)

 

154,933

 

Euro

1/18/24

(70,845,000)

 

74,939,246

 

(3,317,379)

 
         
      

(5,406,471)

  

Goldman Sachs & Co. LLC:

        

Canadian Dollar

1/18/24

(8,409,000)

 

6,144,531

 

(204,071)

 

Euro

1/18/24

(49,244,000)

 

52,738,572

 

(1,657,211)

 
         
      

(1,861,282)

  

HSBC Securities (USA), Inc.:

        

Canadian Dollar

1/18/24

(111,506,000)

 

81,569,503

 

(2,614,975)

 

Euro

1/18/24

(64,160,000)

 

68,321,235

 

(2,551,021)

 
         
      

(5,165,996)

  

JPMorgan Chase Bank, National Association:

        

Canadian Dollar

1/18/24

(178,420,000)

 

130,276,743

 

(4,426,273)

 

Euro

1/18/24

8,132,000

 

(8,637,448)

 

345,302

 

Euro

1/18/24

(15,933,000)

 

17,707,490

 

107,620

 

Euro

1/18/24

(99,238,000)

 

105,468,857

 

(4,151,172)

 
         
      

(8,124,523)

  

Morgan Stanley & Co. International PLC:

        

Canadian Dollar

1/18/24

1,336,000

 

(977,213)

 

31,437

 

Euro

1/18/24

(4,659,000)

 

4,928,113

 

(218,300)

 
         
      

(186,863)

  

State Street Bank and Trust Company:

        

Canadian Dollar

1/18/24

17,035,000

 

(12,373,939)

 

487,096

 

Canadian Dollar

1/18/24

14,887,000

 

(11,249,563)

 

(10,219)

 

Canadian Dollar

1/18/24

(163,996,000)

 

119,861,980

 

(3,951,247)

 

Euro

1/18/24

12,740,000

 

(14,039,698)

 

33,129

 

Euro

1/18/24

(120,976,000)

 

127,981,841

 

(5,650,362)

 
         
      

(9,091,603)

  

Total

    

$

(35,042,237)

  

5


            

Schedule of Total Return Swaps

Counterparty/

Return Paid

by the Fund

 

Return Received

by the Fund

 

Payment

Frequency

 

Termination

Date

 

Notional

Amount

  

Swap Contracts, at Value and

Unrealized

Appreciation/

(Depreciation)

UBS AG, London Branch:

            

Euro short-term rate + 0.55%

 

Ryanair Holdings PLC

 

At Maturity

 

1/8/25

 

25,958,221

EUR

$

303,605

  

Average Ending Monthly Value of Derivative Instruments During the Period Ended December 31, 2023

 

 

 

 

Forward foreign currency exchange contracts:

 

Average amounts purchased - in USD

$91,485,279

Average amounts sold - in USD

986,458,888

Total return swaps:

 

Average notional amount

6,489,555

 

 

 

 

 

 

 

 

6


Notes to Schedule of Investments (unaudited)

  

ADR

American Depositary Receipt

LLC

Limited Liability Company

PLC

Public Limited Company

  

*

Non-income producing security.

  

ºº

Rate shown is the 7-day yield as of December 31, 2023.

  

#

Loaned security; a portion of the security is on loan at December 31, 2023.

  

¢

Security is valued using significant unobservable inputs. The total value of Level 3 securities as of the period ended December 31, 2023 is $24, which represents 0.0% of net assets.

  

£

The Fund may invest in certain securities that are considered affiliated companies. As defined by the Investment Company Act of 1940, as amended, an affiliated company is one in which the Fund owns 5% or more of the outstanding voting securities, or a company which is under common ownership or control.

  

Net of income paid to the securities lending agent and rebates paid to the borrowing counterparties.

              

The following is a summary of the inputs that were used to value the Fund’s investments in securities and other financial instruments as of December 31, 2023.

 

Valuation Inputs Summary

       
    

Level 2 -

 

Level 3 -

  

Level 1 -

 

Other Significant

 

Significant

  

Quoted Prices

 

Observable Inputs

 

Unobservable Inputs

       

Assets

      

Investments In Securities:

      

Common Stocks

$

18,918,161,414

$

-

$

-

Warrants

 

-

 

-

 

24

Investment Companies

 

-

 

771,806,956

 

-

Investments Purchased with Cash Collateral from Securities Lending

 

-

 

222,000

 

-

Total Investments in Securities

$

18,918,161,414

$

772,028,956

$

24

Other Financial Instruments(a):

      

OTC Swaps

 

-

 

303,605

 

-

Forward Foreign Currency Exchange Contracts

 

-

 

2,658,379

 

-

Total Assets

$

18,918,161,414

$

774,990,940

$

24

Liabilities

      

Other Financial Instruments(a):

      

Forward Foreign Currency Exchange Contracts

$

-

$

37,700,616

$

-

       

(a)

Other financial instruments may include forward foreign currency exchange contracts, futures, written options, written swaptions, and swap contracts. Forward foreign currency exchange contracts, futures contracts, and swap contracts are reported at their unrealized appreciation/(depreciation) at measurement date, which represents the change in the contract's value from trade date. Written options and written swaptions are reported at their market value at measurement date.

7


Investment Valuation

Fund holdings are valued in accordance with policies and procedures established by the Adviser pursuant to Rule 2a-5 under the 1940 Act and approved by and subject to the oversight of the Trustees (the “Valuation Procedures”). Equity securities traded on a domestic securities exchange are generally valued at readily available market quotations, which are (i) the official close prices or (ii) last sale prices on the primary market or exchange in which the securities trade. If such price is lacking for the trading period immediately preceding the time of determination, such securities are generally valued at their current bid price. Equity securities that are traded on a foreign exchange are generally valued at the closing prices on such markets. In the event that there is no current trading volume on a particular security in such foreign exchange, the bid price from the primary exchange is generally used to value the security. Foreign securities and currencies are converted to U.S. dollars using the current spot USD dollar exchange rate in effect at the close of the New York Stock Exchange (“NYSE”). The Adviser will determine the market value of individual securities held by it by using prices provided by one or more Adviser-approved professional pricing services or, as needed, by obtaining market quotations from independent broker-dealers. Most debt securities are valued in accordance with the evaluated bid price supplied by the pricing service that is intended to reflect market value. The evaluated bid price supplied by the pricing service is an evaluation that may consider factors such as security prices, yields, maturities and ratings. Certain short-term securities maturing within 60 days or less may be evaluated and valued on an amortized cost basis provided that the amortized cost determined approximates market value. Securities for which market quotations or evaluated prices are not readily available or deemed unreliable are valued at fair value determined in good faith by the Adviser pursuant to the Valuation Procedures. Circumstances in which fair valuation may be utilized include, but are not limited to: (i) a significant event that may affect the securities of a single issuer, such as a merger, bankruptcy, or significant issuer-specific development; (ii) an event that may affect an entire market, such as a natural disaster or significant governmental action; (iii) a nonsignificant event such as a market closing early or not opening, or a security trading halt; and (iv) pricing of a nonvalued security and a restricted or nonpublic security. Special valuation considerations may apply with respect to “odd-lot” fixed-income transactions which, due to their small size, may receive evaluated prices by pricing services which reflect a large block trade and not what actually could be obtained for the odd-lot position. The value of the securities of other mutual funds held by the Fund, if any, will be calculated using the NAV of such mutual funds, and the prospectuses for such mutual funds explain the circumstances under which they use fair valuation and the effects of using fair valuation. The value of the securities of any cash management pooled investment vehicles that operate as money market funds held by the Fund, if any, will be calculated using the NAV of such funds.

Valuation Inputs Summary

FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value, and expands disclosure requirements regarding fair value measurements. This standard emphasizes that fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. These inputs are summarized into three broad levels:

Level 1 – Unadjusted quoted prices in active markets the Fund has the ability to access for identical assets or liabilities.

Level 2 – Observable inputs other than unadjusted quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.

Assets or liabilities categorized as Level 2 in the hierarchy generally include: debt securities fair valued in accordance with the evaluated bid or ask prices supplied by a pricing service; securities traded on OTC markets and listed securities for which no sales are reported that are fair valued at the latest bid price (or yield equivalent thereof) obtained from one or more dealers transacting in a market for such securities or by a pricing service approved by the Fund’s Trustees; certain short-term debt securities with maturities of 60 days or less that are fair valued at amortized cost; and equity securities of foreign issuers whose fair value is determined by using systematic fair valuation models provided by independent third parties in order to adjust for stale pricing which may occur between the close of certain foreign exchanges and the close of the NYSE. Other securities that may be categorized as Level 2 in the hierarchy include, but are not limited to, preferred stocks, bank loans, swaps, investments in unregistered investment companies, options, and forward contracts.

Level 3 – Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing the Fund’s own assumptions about the assumptions that a market participant would use in valuing the asset or liability, and that would be based on the best information available.

There have been no significant changes in valuation techniques used in valuing any such positions held by the Fund since the beginning of the fiscal period.

The inputs or methodology used for fair valuing securities are not necessarily an indication of the risk associated with investing in those securities. The summary of inputs used as of December 31, 2023 to fair value the Fund’s investments

8


in securities and other financial instruments is included in the “Valuation Inputs Summary” in the Notes to Schedule of Investments.

The following describes the amounts of transfers into or out of Level 3 of the fair value hierarchy during the period.

Financial assets of $24 were transferred out of Level 2 to Level 3 since certain security’s prices were determined using significant unobservable inputs at the end of the current period and other significant observable inputs at the end of the prior year.

The Fund did not hold a significant amount of Level 3 securities as of December 31, 2023.

9


For additional information on the Fund, please refer to the Fund’s most recent semiannual or annual shareholder report.

      
      
      
   

125-25-70218 02-24